1-3 of 3
Sharyn D. Baker
Close
Sort by
Journal Articles

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J. Orwick, Daelynn R. Buelow, Sydney Fobare, Christopher C. Oakes, Jonathan E. Kolitz, Geoff Uy, Wendy Stock, Bayard L. Powell, Deedra Nicolet, Erin K. Hertlein, Krzysztof Mrózek, James S. Blachly, Ann-Kathrin Eisfeld, Sharyn D. Baker, John C. Byrd
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4671–4675.
https://doi.org/10.1182/bloodadvances.2023010482
Published: 2023
Includes: Supplemental data
Journal Articles

BMX kinase mediates gilteritinib resistance in FLT3 -mutated AML through microenvironmental factors

Daelynn R. Buelow, Bhavana Bhatnagar, Shelley J. Orwick, Jae Yoon Jeon, Eric D. Eisenmann, Jack C. Stromatt, Navjot Singh Pabla, James S. Blachly, Sharyn D. Baker, Bradley W. Blaser
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5049–5060.
https://doi.org/10.1182/bloodadvances.2022007952
Published: 2022
Includes: Supplemental data
Journal Articles

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

Megan E. Zavorka Thomas, Jae Yoon Jeon, Zahra Talebi, Daelynn R. Buelow, Josie Silvaroli, Moray J. Campbell, Alex Sparreboom, Navjot Pabla, Sharyn D. Baker
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5041–5046.
https://doi.org/10.1182/bloodadvances.2021005614
Published: 2021
Includes: Supplemental data